Loading clinical trials...

A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage | Clinical Trials | Clareo Health

COMPLETED

A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

A Non-Interventional Clinical Study to Assess the Risk and Performance Aspects of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

NCT05126407•Johnson & Johnson Consumer Inc. (J&JCI)

View on ClinicalTrials.gov

Summary

The purpose of this study is to proactively collect customer feedback on the performance aspects and risk factors of Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Aged 18 years or older who has personally used or administered the nasal drops/spray to a child
•Has personally used or administered to a child, the Nasal Drops/Spray at least once within the past 6 months
•Able to read, write, speak, and understand German
•Has internet access to complete an on-line survey
•Intends to complete the survey
•Individual has signed the informed consent document (ICD)

Exclusion Criteria

•\- Is an employee/contractor or immediate family member of the principal investigator (PI), Schlesinger group, product perceptions limited (PPL) Insights or sponsor of this study

Locations (1)

Schlesinger Group

Berlin, Germany

Key Dates

Start Date

December 17, 2021

Primary Completion Date

January 20, 2022

Completion Date

January 20, 2022

Last Updated

February 1, 2023

Enrollment

ACTUAL participants

Conditions

Common ColdSinusitisHypersensitivity

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

NCT06406114

Drug AllergyCephalosporin Allergy+5 more

View study

RECRUITINGPHASE2

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

NCT06914908

Chronic Rhinosinusitis With Nasal Polyps

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 1, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

Inclusion Criteria

Exclusion Criteria

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients

Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis

Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy

Goat vs. Cow Milk Digestive Tolerance